Clinical Pharmacology in Drug Development
Publisher: Wiley ·
ISSN 2160763X ·
8 articles
-
Bioequivalence Studies of Two Fixed‐Dose Combination of Dapagliflozin and Metformin XR Formulations in Healthy Participants Under Fed and Fasting Conditions
Gökçe Sözer,
Ahmad Abdulkhaleq,
Iyad Zead,
Rana Zeidan
Clinical Pharmacology in Drug Development
· Pharmacology (medical)
· 2026-11-21
-
A Randomized Euglycemic Clamp Study to Demonstrate Bioequivalence of Biosimilar and Reference Ultra‐Long‐Acting Insulin Degludec in Healthy Volunteers
Sergei Noskov,
Ekaterina Koksharova,
Anna Arefeva,
Veniamin Banko,
Kseniia Radaeva,
Dmitrii Iliushchenko,
Igor Makarenko,
Roman Drai
Clinical Pharmacology in Drug Development
· Pharmacology (medical)
· 2026-11-21
-
Comparative Pharmacokinetics and Bioequivalence Assessment of Vonoprazan Fumarate Tablet in Fasting and Fed Conditions: A Randomized Study in Healthy Chinese Subjects
Hongcheng Li,
Fuzhou Wang,
Yanan Huang,
Hongdan Cai,
Jingshu Zhang,
Bin Liu,
Xiaohui Li
Clinical Pharmacology in Drug Development
· Pharmacology (medical)
· 2026-11-21
-
Drug–Drug Interaction Assessment of WXFL10203614 With Rifampicin, Itraconazole and Metformin: A Three‐Cohort Phase I Study
Jinmei Zhou,
Mengshuang Gao,
Daolei Zhou,
Zhiwei Zhang,
Huan Zhang,
Yu Sun,
Huan Zhou
Clinical Pharmacology in Drug Development
· Pharmacology (medical)
· 2026-11-14
-
Pharmacogenomics as a Design Input in Early‐Phase Drug Development
Amalia M. Issa
Clinical Pharmacology in Drug Development
· Pharmacology (medical)
· 2026-11-06
-
Comparability of Pharmacokinetics, Safety, and Tolerability of Canakinumab Administration With One Injection (200 mg) of Pre‐Filled Syringe or Auto‐Injector Versus Two Injections (150 and 50 mg) of Pre‐Filled Syringe in Healthy Subjects
Abhijit Chakraborty,
Anshu Marathe,
Jong Bong Lee,
Kari Wiedinger,
Britta Zehnpfennig,
Carole Schuhler,
Simantini Eddy,
Michelle Quinlan
Clinical Pharmacology in Drug Development
· Pharmacology (medical)
· 2026-11-04
-
Issue Information
Clinical Pharmacology in Drug Development
· Pharmacology (medical)
· 2026-11-02
-
A First‐In‐Human, Randomized, Placebo‐Controlled Single and Multiple Ascending Dose Study of Izicopan (INF904), A Second‐Generation Oral Small Molecule C5a Receptor Inhibitor, in Healthy Participants
Joseph F. Grippo,
Anja Pfaff,
Zhongli Xu,
Isabell Otto,
Claus Thielert,
Mihaly Imre,
Rui Liu,
Wantanee Phuapradit,
Yazhong Pei,
Cuie Chen,
Maria Habel,
Renfeng Guo,
Camilla Chong
Clinical Pharmacology in Drug Development
· Pharmacology (medical)
· 2026-11-02